We are live on
!
Find out more
KCM
Knoll Capital Management Portfolio holdings
AUM
$180M
1-Year Est. Return
66.11%
This Fund
S&P 500
This Quarter
Est. Return
+14.76%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$121M
AUM Growth
+$24.4M
(+25%)
Cap. Flow
+$9.05M
Cap. Flow
% of AUM
7.49%
Top 10 Holdings %
Top 10 Hldgs %
74.17%
Holding
41
New
4
Increased
9
Reduced
1
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aldeyra Therapeutics
ALDX
|
+$7.54M |
| 2 |
Global X Silver Miners ETF NEW
SIL
|
+$2.22M |
| 3 |
Entera Bio
ENTX
|
+$953K |
| 4 |
Philip Morris
PM
|
+$921K |
| 5 |
iShares US Aerospace & Defense ETF
ITA
|
+$883K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Franco-Nevada
FNV
|
+$1.94M |
| 2 |
First Majestic Silver
AG
|
+$1.41M |
| 3 |
Altria Group
MO
|
+$955K |
| 4 |
Lockheed Martin
LMT
|
+$879K |
| 5 |
Pan American Silver
PAAS
|
+$783K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 69.45% |
| 2 | Materials | 17.23% |
| 3 | Industrials | 2.22% |
| 4 | Financials | 1.04% |
| 5 | Consumer Staples | 0.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
iShares US Aerospace & Defense ETF
ITA
$15B
| $968K | 0.8% |
+7,650
| New | +$883K |
|
|
NEWP
27
New Pacific Metals
NEWP
$1.17B
| $926K | 0.77% |
485,000
+353,346
| +268% | +$610K |
|
28
Royal Gold
RGLD
$19.5B
| $913K | 0.76% |
7,550
| – | – |
|
29
Ocular Therapeutix
OCUL
$2.02B
| $894K | 0.74% |
200,400
+200,000
| +50,000% | +$591K |
|
|
MREO
30
Mereo BioPharma
MREO
$47.3M
| $370K | 0.31% |
+160,470
| New | +$307K |
|
|
IRD
31
Opus Genetics
IRD
$302M
| $301K | 0.25% |
100,000
| – | – |
|
|
32
First Majestic Silver
AG
$9.07B
| – | – |
-275,000
| Closed | -$1.41M |
|
33
Amylyx Pharmaceuticals
AMLX
$2.54B
| – | – |
-24,772
| Closed | -$454K |
|
34
BioXcel Therapeutics
BTAI
$27.8M
| – | – |
-3,750
| Closed | -$152K |
|
|
35
Franco-Nevada
FNV
$46B
| – | – |
-14,500
| Closed | -$1.94M |
|
|
36
Lockheed Martin
LMT
$136B
| – | – |
-2,150
| Closed | -$879K |
|
|
37
Altria Group
MO
$114B
| – | – |
-22,700
| Closed | -$955K |
|
38
OR Royalties Inc
OR
$6.2B
| – | – |
-400,000
| Closed | -$732K |
|
|
39
Pan American Silver
PAAS
$21.6B
| – | – |
-54,085
| Closed | -$783K |
|
|
OMGA
40
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| – | – |
-173,010
| Closed | -$372K |
|
Similar funds
FBC
AIC
AG
PCA
HIC
FFA
V
RVM
Knoll Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Knoll Capital Management held 41 positions worth $121M, up 25% from $96.3M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Knoll Capital Management deployed $9.05M of net new capital in Q4 2023, opening 4 new positions and adding to 9 existing holdings. Its largest new stake was Philip Morris: 10,000 shares worth $1.01M.
By sector, the portfolio is most concentrated in Healthcare at 69% of assets, up from 66% a quarter earlier, followed by Materials and Industrials.
On the sell side, the largest reduction was MAG Silver, an estimated $588K trimmed.
- Knoll Capital Management's largest Q4 2023 buy was Philip Morris: 10,000 shares worth $1.01M.
- Knoll Capital Management added most to Aldeyra Therapeutics in Q4 2023, an estimated $7.54M increase.
- Knoll Capital Management's biggest Q4 2023 reduction was MAG Silver, cutting an estimated $588K.
- Knoll Capital Management fully exited Franco-Nevada in Q4 2023, selling an estimated $1.94M.
- Knoll Capital Management's ten largest holdings make up 74% of its $121M portfolio in Q4 2023.
- Knoll Capital Management opened 4 new positions and closed 9 in Q4 2023.
- Knoll Capital Management's portfolio value rose 25% quarter-over-quarter to $121M.
Based on Knoll Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.